| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9442 |
| Human Intestinal Absorption | HIA+ | 0.9890 |
| Caco-2 Permeability | Caco2+ | 0.7680 |
| P-glycoprotein Substrate | Non-substrate | 0.7779 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8882 |
| Non-inhibitor | 0.8780 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8299 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7692 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8160 |
| CYP450 2D6 Substrate | Non-substrate | 0.7856 |
| CYP450 3A4 Substrate | Non-substrate | 0.5076 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5937 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9298 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9311 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8916 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9613 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6852 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9606 |
| Non-inhibitor | 0.8869 |
| AMES Toxicity | Non AMES toxic | 0.5614 |
| Carcinogens | Carcinogens | 0.6637 |
| Fish Toxicity | High FHMT | 0.8263 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8915 |
| Honey Bee Toxicity | Low HBT | 0.5447 |
| Biodegradation | Not ready biodegradable | 0.7585 |
| Acute Oral Toxicity | III | 0.5094 |
| Carcinogenicity (Three-class) | Non-required | 0.4767 |